Human Epigenome Project
Human Epigenome Project (HEP) is a multinational science project, with the stated aim to "identify, catalog, and interpret genome-wide DNA methylation patterns of all human genes in all major tissues".[1] It is financed by government funds as well as private investment, via a consortium of genetic research organisations.
The call for such a project was widely suggested and supported by cancer research scientists from all over the world.[2][3][4][5]
Consortium
The HEP consortium is made up of the following organizations:
- The Wellcome Trust Sanger Institute — UK
- Epigenomics AG — Germany/USA
- The Centre National de Génotypage — France
See also
References
- "Description Page". Human Epigenome Project. Archived from the original on 2009-10-10. Retrieved 2009-01-30.
- Esteller M (2006). "The necessity of a human epigenome project". Carcinogenesis. 27 (6): 1121–1125. doi:10.1093/carcin/bgl033. PMID 16699174.
- Jones PA, Martienssen R (2005). "A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop". Cancer Res. 65 (24): 11241–11246. doi:10.1158/0008-5472.CAN-05-3865. PMID 16357125.
- Rauscher FJ 3rd (2005). "It is time for a Human Epigenome Project". Cancer Res. 65 (24): 11229. doi:10.1158/0008-5472.can-65-24-ed1. PMID 16357122.
- Bradbury J (2003). "Human epigenome project--up and running". PLoS Biol. 1 (3): E82. doi:10.1371/journal.pbio.0000082. PMC 300691. PMID 14691553.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.